P300 is elevated in systemic sclerosis and its expression is positively regulated by TGF-β

Epigenetic feed-forward amplification of fibrosis

Asish K Ghosh, Swati Bhattacharyya*, Robert Lafyatis, Giuseppina Farina, Jianxiu Yu, Bayar Thimmapaya, Jun Wei, John Varga

*Corresponding author for this work

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Fibrosis, the hallmark of systemic sclerosis (SSc), is characterized by persistent fibroblast activation triggered by transforming growth factor-β (TGF-β). As the acetyltransferase p300 has a key role in fibrosis and its availability governs the intensity of fibrotic responses, we investigated p300 expression in SSc and the molecular basis of its regulation. We found that expression of p300 was markedly elevated in SSc skin biopsies and was induced by TGF-β in explanted normal skin fibroblasts. Stimulation of p300 by TGF-β was independent of Smads and involved the early-immediate transcription factor Egr-1 (early growth response 1), a key regulator of profibrotic TGF-β signaling. Indeed, Egr-1 was both sufficient and necessary for p300 regulation in vitro and in vivo. Increased p300 accumulation in TGF-β-treated fibroblasts was associated with histone hyperacetylation, whereas p300 depletion, or selective pharmacological blockade of its acetyltransferase activity, attenuated TGF-β-induced responses. Moreover, TGF-β enhanced both p300 recruitment and in vivo histone H4 acetylation at the COL1A2 (collagen, type I, α2) locus. These findings implicate p300-mediated histone acetylation as a fundamental epigenetic mechanism in fibrogenesis and place Egr-1 upstream in TGF-β-driven stimulation of p300 gene expression. The results establish a firm link between fibrosis with aberrant p300 expression and epigenetic activity that, to our knowledge, is previously unreported. Targeted disruption of p300-mediated histone acetylation might therefore represent a viable antifibrotic strategy.

Original languageEnglish (US)
Pages (from-to)1302-1310
Number of pages9
JournalJournal of Investigative Dermatology
Volume133
Issue number5
DOIs
StatePublished - Jan 1 2013

Fingerprint

Systemic Scleroderma
Transforming Growth Factors
Epigenomics
Amplification
Fibrosis
Acetylation
Histones
Fibroblasts
Skin
Early Growth Response Protein 1
Acetyltransferases
Collagen Type II
Biopsy
Growth
Collagen Type I
Gene expression
Chemical activation
Availability
Pharmacology
Gene Expression

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Dermatology
  • Cell Biology

Cite this

@article{d3159b74061949809c9bbcb75f489150,
title = "P300 is elevated in systemic sclerosis and its expression is positively regulated by TGF-β: Epigenetic feed-forward amplification of fibrosis",
abstract = "Fibrosis, the hallmark of systemic sclerosis (SSc), is characterized by persistent fibroblast activation triggered by transforming growth factor-β (TGF-β). As the acetyltransferase p300 has a key role in fibrosis and its availability governs the intensity of fibrotic responses, we investigated p300 expression in SSc and the molecular basis of its regulation. We found that expression of p300 was markedly elevated in SSc skin biopsies and was induced by TGF-β in explanted normal skin fibroblasts. Stimulation of p300 by TGF-β was independent of Smads and involved the early-immediate transcription factor Egr-1 (early growth response 1), a key regulator of profibrotic TGF-β signaling. Indeed, Egr-1 was both sufficient and necessary for p300 regulation in vitro and in vivo. Increased p300 accumulation in TGF-β-treated fibroblasts was associated with histone hyperacetylation, whereas p300 depletion, or selective pharmacological blockade of its acetyltransferase activity, attenuated TGF-β-induced responses. Moreover, TGF-β enhanced both p300 recruitment and in vivo histone H4 acetylation at the COL1A2 (collagen, type I, α2) locus. These findings implicate p300-mediated histone acetylation as a fundamental epigenetic mechanism in fibrogenesis and place Egr-1 upstream in TGF-β-driven stimulation of p300 gene expression. The results establish a firm link between fibrosis with aberrant p300 expression and epigenetic activity that, to our knowledge, is previously unreported. Targeted disruption of p300-mediated histone acetylation might therefore represent a viable antifibrotic strategy.",
author = "Ghosh, {Asish K} and Swati Bhattacharyya and Robert Lafyatis and Giuseppina Farina and Jianxiu Yu and Bayar Thimmapaya and Jun Wei and John Varga",
year = "2013",
month = "1",
day = "1",
doi = "10.1038/jid.2012.479",
language = "English (US)",
volume = "133",
pages = "1302--1310",
journal = "Journal of Investigative Dermatology",
issn = "0022-202X",
publisher = "Nature Publishing Group",
number = "5",

}

P300 is elevated in systemic sclerosis and its expression is positively regulated by TGF-β : Epigenetic feed-forward amplification of fibrosis. / Ghosh, Asish K; Bhattacharyya, Swati; Lafyatis, Robert; Farina, Giuseppina; Yu, Jianxiu; Thimmapaya, Bayar; Wei, Jun; Varga, John.

In: Journal of Investigative Dermatology, Vol. 133, No. 5, 01.01.2013, p. 1302-1310.

Research output: Contribution to journalArticle

TY - JOUR

T1 - P300 is elevated in systemic sclerosis and its expression is positively regulated by TGF-β

T2 - Epigenetic feed-forward amplification of fibrosis

AU - Ghosh, Asish K

AU - Bhattacharyya, Swati

AU - Lafyatis, Robert

AU - Farina, Giuseppina

AU - Yu, Jianxiu

AU - Thimmapaya, Bayar

AU - Wei, Jun

AU - Varga, John

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Fibrosis, the hallmark of systemic sclerosis (SSc), is characterized by persistent fibroblast activation triggered by transforming growth factor-β (TGF-β). As the acetyltransferase p300 has a key role in fibrosis and its availability governs the intensity of fibrotic responses, we investigated p300 expression in SSc and the molecular basis of its regulation. We found that expression of p300 was markedly elevated in SSc skin biopsies and was induced by TGF-β in explanted normal skin fibroblasts. Stimulation of p300 by TGF-β was independent of Smads and involved the early-immediate transcription factor Egr-1 (early growth response 1), a key regulator of profibrotic TGF-β signaling. Indeed, Egr-1 was both sufficient and necessary for p300 regulation in vitro and in vivo. Increased p300 accumulation in TGF-β-treated fibroblasts was associated with histone hyperacetylation, whereas p300 depletion, or selective pharmacological blockade of its acetyltransferase activity, attenuated TGF-β-induced responses. Moreover, TGF-β enhanced both p300 recruitment and in vivo histone H4 acetylation at the COL1A2 (collagen, type I, α2) locus. These findings implicate p300-mediated histone acetylation as a fundamental epigenetic mechanism in fibrogenesis and place Egr-1 upstream in TGF-β-driven stimulation of p300 gene expression. The results establish a firm link between fibrosis with aberrant p300 expression and epigenetic activity that, to our knowledge, is previously unreported. Targeted disruption of p300-mediated histone acetylation might therefore represent a viable antifibrotic strategy.

AB - Fibrosis, the hallmark of systemic sclerosis (SSc), is characterized by persistent fibroblast activation triggered by transforming growth factor-β (TGF-β). As the acetyltransferase p300 has a key role in fibrosis and its availability governs the intensity of fibrotic responses, we investigated p300 expression in SSc and the molecular basis of its regulation. We found that expression of p300 was markedly elevated in SSc skin biopsies and was induced by TGF-β in explanted normal skin fibroblasts. Stimulation of p300 by TGF-β was independent of Smads and involved the early-immediate transcription factor Egr-1 (early growth response 1), a key regulator of profibrotic TGF-β signaling. Indeed, Egr-1 was both sufficient and necessary for p300 regulation in vitro and in vivo. Increased p300 accumulation in TGF-β-treated fibroblasts was associated with histone hyperacetylation, whereas p300 depletion, or selective pharmacological blockade of its acetyltransferase activity, attenuated TGF-β-induced responses. Moreover, TGF-β enhanced both p300 recruitment and in vivo histone H4 acetylation at the COL1A2 (collagen, type I, α2) locus. These findings implicate p300-mediated histone acetylation as a fundamental epigenetic mechanism in fibrogenesis and place Egr-1 upstream in TGF-β-driven stimulation of p300 gene expression. The results establish a firm link between fibrosis with aberrant p300 expression and epigenetic activity that, to our knowledge, is previously unreported. Targeted disruption of p300-mediated histone acetylation might therefore represent a viable antifibrotic strategy.

UR - http://www.scopus.com/inward/record.url?scp=84876684186&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876684186&partnerID=8YFLogxK

U2 - 10.1038/jid.2012.479

DO - 10.1038/jid.2012.479

M3 - Article

VL - 133

SP - 1302

EP - 1310

JO - Journal of Investigative Dermatology

JF - Journal of Investigative Dermatology

SN - 0022-202X

IS - 5

ER -